Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Electromed Inc (ELMD)

Electromed Inc (ELMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 152,312
  • Shares Outstanding, K 8,605
  • Annual Sales, $ 48,070 K
  • Annual Income, $ 3,170 K
  • 60-Month Beta 0.40
  • Price/Sales 3.31
  • Price/Cash Flow 40.35
  • Price/Book 3.79
Trade ELMD with:

Options Overview Details

View History
  • Implied Volatility 52.54% ( -8.37%)
  • Historical Volatility 46.33%
  • IV Percentile 64%
  • IV Rank 54.75%
  • IV High 90.79% on 02/14/24
  • IV Low 6.26% on 10/05/23
  • Put/Call Vol Ratio 2.00
  • Today's Volume 9
  • Volume Avg (30-Day) 20
  • Put/Call OI Ratio 1.24
  • Today's Open Interest 1,075
  • Open Int (30-Day) 952

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.04
  • Growth Rate Est. (year over year) +2,497,400.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.90 +25.97%
on 04/18/24
18.60 -5.86%
on 05/06/24
+2.14 (+13.92%)
since 04/05/24
3-Month
9.96 +75.80%
on 02/08/24
18.60 -5.86%
on 05/06/24
+7.49 (+74.75%)
since 02/07/24
52-Week
8.80 +98.98%
on 08/21/23
18.60 -5.86%
on 05/06/24
+6.26 (+55.64%)
since 05/05/23

Most Recent Stories

More News
Electromed, Inc. to Participate in the Inaugural EF Hutton Global Conference

Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive...

ELMD : 17.51 (-1.07%)
Electromed, Inc. Schedules its Third Quarter Fiscal 2023 Financial Results Conference Call for May 9, 2023 at 5:00 p.m. ET

Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release...

ELMD : 17.51 (-1.07%)
Electromed, Inc. Announces Fiscal 2023 Second Quarter Results

Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended December 31, 2022 (“Q2 FY...

ELMD : 17.51 (-1.07%)
Electromed Announces Chief Executive Officer Retirement and Succession Plan

Electromed, Inc. (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan will retire as President and Chief Executive Officer with a target effective...

ELMD : 17.51 (-1.07%)
Electromed, Inc. Schedules its Second Quarter Fiscal 2023 Financial Results Conference Call for February 14, 2023 at 5:00 p.m. ET

Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release...

ELMD : 17.51 (-1.07%)
Electromed, Inc. Announces U.S. Food and Drug Administration 510(k) Clearance of Fifth Generation HFCWO Airway Clearance Generator

Electromed, Inc. (NYSE American: ELMD) a leader in innovative airway clearance technologies, today announced that it received U.S Food and Drug Administration (“FDA”) 510(k) clearance of the SmartVest...

ELMD : 17.51 (-1.07%)
Electromed, Inc. Announces Fiscal 2023 First Quarter Results

Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended September...

ELMD : 17.51 (-1.07%)
Electromed, Inc. to Participate in Two Upcoming Investor Conferences

Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that management is scheduled to participate in two...

ELMD : 17.51 (-1.07%)
Electromed, Inc. Schedules its First Quarter Fiscal 2023 Financial Results Conference Call for November 8, 2022 at 5:00 p.m. PT

Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release...

ELMD : 17.51 (-1.07%)
Electromed, Inc. Appoints Brad Nagel as Chief Financial Officer

Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that its Board of Directors has appointed Brad Nagel...

ELMD : 17.51 (-1.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Electromed, Inc. manufactures, markets and sells products that provide airway clearance therapy to patients with compromised pulmonary function. The Company is the designer, manufacturer and worldwide provider of the SmartVest' Airway Clearance System and related products. The patented system uses High...

See More

Key Turning Points

3rd Resistance Point 19.05
2nd Resistance Point 18.66
1st Resistance Point 18.09
Last Price 17.51
1st Support Level 17.13
2nd Support Level 16.74
3rd Support Level 16.17

See More

52-Week High 18.60
Last Price 17.51
Fibonacci 61.8% 14.86
Fibonacci 50% 13.70
Fibonacci 38.2% 12.54
52-Week Low 8.80

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar